| GC33480-50mg |
|
18656-96-7 |
|
0 |
C26H36BrClN2O7 |
|
|
|
| GC33480-10mM(1mLinDMSO) |
|
18656-96-7 |
|
0 |
C26H36BrClN2O7 |
|
|
|
| GC33479-5g |
|
79983-71-4 |
Hexaconazole ((-)-Hexaconazol)
|
0 |
C14H17Cl2N3O |
|
|
|
| GC33479-1g |
|
79983-71-4 |
Hexaconazole ((-)-Hexaconazol)
|
0 |
C14H17Cl2N3O |
|
|
|
| GC33479-500mg |
|
79983-71-4 |
Hexaconazole ((-)-Hexaconazol)
|
0 |
C14H17Cl2N3O |
|
|
|
| GC33479-100mg |
|
79983-71-4 |
Hexaconazole ((-)-Hexaconazol)
|
0 |
C14H17Cl2N3O |
|
|
|
| GC33479-10mM(1mLinDMSO) |
|
79983-71-4 |
Hexaconazole ((-)-Hexaconazol)
|
0 |
C14H17Cl2N3O |
|
|
|
| GC33478-10mg |
|
13656-81-0 |
Nezukone (C2-deoxyhinokitiol)
|
0 |
C10H12O |
|
|
|
| GC33478-5mg |
|
13656-81-0 |
Nezukone (C2-deoxyhinokitiol)
|
0 |
C10H12O |
|
|
|
| GC33478-10mM(1mLinDMSO) |
|
13656-81-0 |
Nezukone (C2-deoxyhinokitiol)
|
0 |
C10H12O |
|
|
|
| GC33477-5g |
|
5025-82-1 |
Folcisteine (3-Acetylthiazolidine-4-carboxylic acid)
|
0 |
C6H9NO3S |
|
|
|
| GC33477-1g |
|
5025-82-1 |
Folcisteine (3-Acetylthiazolidine-4-carboxylic acid)
|
0 |
C6H9NO3S |
|
|
|
| GC33477-500mg |
|
5025-82-1 |
Folcisteine (3-Acetylthiazolidine-4-carboxylic acid)
|
0 |
C6H9NO3S |
|
|
|
| GC33477-100mg |
|
5025-82-1 |
Folcisteine (3-Acetylthiazolidine-4-carboxylic acid)
|
0 |
C6H9NO3S |
|
|
|
| GC33477-10mM(1mLinDMSO) |
|
5025-82-1 |
Folcisteine (3-Acetylthiazolidine-4-carboxylic acid)
|
0 |
C6H9NO3S |
|
|
|
| GC33476-50mg |
|
871258-12-7 |
|
0 |
C41H77NO2 |
|
|
|
| GC33476-10mM(1mLinDMSO) |
|
871258-12-7 |
|
0 |
C41H77NO2 |
|
|
|
| GC33475-100mL |
|
127-19-5 |
|
0 |
C4H9NO |
|
|
|
| GC33474-500mg |
|
9 |
BCIP (BCIP p-toluidine salt)
|
0 |
C15H15BrClN2O4P |
|
|
|
| GC33474-100mg |
|
9 |
BCIP (BCIP p-toluidine salt)
|
0 |
C15H15BrClN2O4P |
|
|
|
